Literature DB >> 15103415

[Fulminant meningoencephalitis associated with Mycoplasma pneumoniae infection in adults. Aggressive treatment enabled a good outcome].

Roland Sparing1, Christoph Spitzer, Helga Häfner, Dirk Zolldann, Marcus H T Reinges, Timo Krings, Johannes Noth, Christoph M Kosinski.   

Abstract

Mycoplasma pneumoniae (M. pn.) commonly causes respiratory tract infections in humans. In a certain percentage of cases it may also be associated with various peripheral and central nervous system manifestations. We report a case of a 38-year-old previously healthy man who presented with hemiplegia and somnolence after he had suffered from a febrile respiratory infection 10 days earlier. Clinical features and laboratory investigations supported the diagnosis of an acute M. pneumoniae-associated meningoencephalitis. He was treated by an aggressive antibiotic and immunomodulatory regimen over the course of several weeks in the neurocritical care unit. Decompressive hemicraniectomy was performed due to life-threatening raised intracranial pressure. However, the patient recovered almost completely and presented with a mild neurological deficit after 3 months. Based on this case we give a review of the literature and discuss potential pathomechanisms and diagnostic approaches.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15103415     DOI: 10.1007/s00115-004-1718-3

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  20 in total

1.  Molecular approaches to diagnosis of pulmonary diseases due to Mycoplasma pneumoniae.

Authors:  M Abele-Horn; U Busch; H Nitschko; E Jacobs; R Bax; F Pfaff; B Schaffer; J Heesemann
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

2.  [Demonstration of mycoplasma pneumoniae in cerebrospinal fluid in acute polyneuritis].

Authors:  P Fleischhauer; U Hüben; H Mertens; K K Sethi; D Thürmann
Journal:  Dtsch Med Wochenschr       Date:  1972-04-28       Impact factor: 0.628

3.  Isolation and characterization of Mycoplasma pneumoniae from cerebrospinal fluid of a patient with pneumonia and meningoencephalitis.

Authors:  I Kasahara; Y Otsubo; T Yanase; H Oshima; H Ichimaru; M Nakamura
Journal:  J Infect Dis       Date:  1985-10       Impact factor: 5.226

Review 4.  Mycoplasmas as agents of human disease.

Authors:  G H Cassell; B C Cole
Journal:  N Engl J Med       Date:  1981-01-08       Impact factor: 91.245

5.  Post-infectious central and peripheral nervous system diseases complicating Mycoplasma pneumoniae infection. Report of three cases and review of the literature.

Authors:  B Pfausler; K Engelhardt; A Kampfl; H Spiss; E Taferner; E Schmutzhard
Journal:  Eur J Neurol       Date:  2002-01       Impact factor: 6.089

6.  Acute disseminated encephalomyelitis (ADEM) due to Mycoplasma pneumoniae infection in an adolescent.

Authors:  K Riedel; V A Kempf; A Bechtold; M Klimmer
Journal:  Infection       Date:  2001-08       Impact factor: 3.553

7.  Post-infectious encephalitis with anti-galactocerebroside antibody subsequent to Mycoplasma pneumoniae infection.

Authors:  M Nishimura; T Saida; S Kuroki; T Kawabata; H Obayashi; K Saida; T Uchiyama
Journal:  J Neurol Sci       Date:  1996-09-01       Impact factor: 3.181

8.  Intrathecal synthesis of specific antibodies in patients with invasion of the central nervous system by Mycoplasma pneumoniae.

Authors:  D Bencina; P Dovc; M Mueller-Premru; T Avsic-Zupanc; M Socan; B Beovic; M Arnez; M Narat
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-07       Impact factor: 3.267

9.  Anticentriolar autoantibodies in children with central nervous system manifestations of Mycoplasma pneumoniae infection.

Authors:  N Cimolai; D Mah; E Roland
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-05       Impact factor: 10.154

10.  Mycoplasma pulmonis infection in the brains of rodents.

Authors:  A Hill
Journal:  J Infect Dis       Date:  1983-03       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.